INTERLEUKIN-5 SYNTHESIS BY EOSINOPHILS - ASSOCIATION WITH GRANULES AND IMMUNOGLOBULIN-DEPENDENT SECRETION

被引:255
作者
DUBUCQUOI, S
DESREUMAUX, P
JANIN, A
KLEIN, O
GOLDMAN, M
TAVERNIER, J
CAPRON, M
CAPRON, A
机构
[1] CHRU,HOP CALMETTE,F-59000 LILLE,FRANCE
[2] CHRU,HOP HURIEZ,SERV GASTROENTEROL,F-59000 LILLE,FRANCE
[3] HOP ERASME,DEPT IMMUNOL,B-1070 BRUSSELS,BELGIUM
[4] ROCHE RES GENT,B-9000 GHENT,BELGIUM
[5] INST PASTEUR,CIBP,F-59019 LILLE,FRANCE
关键词
D O I
10.1084/jem.179.2.703
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 5 (IL-5) is the main factor that promotes the terminal differentiation of eosinophil progenitors (as indicated by colony formation assays), and enhances the effector capacity of mature eosinophils. IL-5 is produced by T lymphocytes, CD4(-)/CD8(-) and mast cells and recently, messenger (m)RNA of this cytokine has been identified in eosinophils from patients with coeliac disease, asthma, or eosinophilic heart diseases. In this study, IL-5 mRNA and immunoreactive IL-5 protein were detected in tissue and blood eosinophils from patients with eosinophilic cystitis or hypereosinophilic syndromes but not in Crohn's disease. By electron microscopy associated to immunogold staining, immunoreactive IL-5 was identified in eosinophilic granules. After stimulation with IgA-, IgE-, or IgG-immune complexes, blood eosinophils were shown, by immunocytochemistry and by enzyme-linked immunosorbent assay, to secrete IL-5. These observations demonstrate that eosinophils, under physiological stimulation, can release significant amounts of IL-5, which may contribute to local eosinophil recruitment and activation.
引用
收藏
页码:703 / 708
页数:6
相关论文
共 19 条
  • [1] IMMUNOBIOLOGY AND IMMUNOPATHOLOGY OF HUMAN GUT MUCOSA - HUMORAL IMMUNITY AND INTRAEPITHELIAL LYMPHOCYTES
    BRANDTZAEG, P
    HALSTENSEN, TS
    KETT, K
    KRAJCI, P
    KVALE, D
    ROGNUM, TO
    SCOTT, H
    SOLLID, LM
    [J]. GASTROENTEROLOGY, 1989, 97 (06) : 1562 - 1584
  • [2] BRAUM LR, 1993, EUR J IMMUNOL, V23, P956
  • [3] EOSINOPHILS EXPRESS INTERLEUKIN-5 AND GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR MESSENGER-RNA AT SITES OF ALLERGIC INFLAMMATION IN ASTHMATICS
    BROIDE, DH
    PAINE, MM
    FIRESTEIN, GS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) : 1414 - 1424
  • [4] DESREUMAUX P, 1993, BLOOD, V82, P1553
  • [5] INTERLEUKIN-5 MESSENGER-RNA EXPRESSION BY EOSINOPHILS IN THE INTESTINAL-MUCOSA OF PATIENTS WITH CELIAC-DISEASE
    DESREUMAUX, P
    JANIN, A
    COLOMBEL, JF
    PRIN, L
    PLUMAS, J
    EMILIE, D
    TORPIER, G
    CAPRON, A
    CAPRON, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) : 293 - 296
  • [6] GHAZALEH RA, 1989, J IMMUNOL, V142, P2393
  • [7] RELEASE OF BOTH PREFORMED AND NEWLY SYNTHESIZED TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA)/CACHECTIN BY MOUSE MAST-CELLS STIMULATED VIA THE FC-EPSILON-RI - A MECHANISM FOR THE SUSTAINED ACTION OF MAST-CELL DERIVED TNF-ALPHA DURING IGE-DEPENDENT BIOLOGICAL RESPONSES
    GORDON, JR
    GALLI, SJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) : 103 - 107
  • [8] RECOMBINANT HUMAN INTERLEUKIN-5 IS A SELECTIVE ACTIVATOR OF HUMAN EOSINOPHIL FUNCTION
    LOPEZ, AF
    SANDERSON, CJ
    GAMBLE, JR
    CAMPBELL, HD
    YOUNG, IG
    VADAS, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) : 219 - 224
  • [9] ALKALINE-PHOSPHATASE AND PEROXIDASE FOR DOUBLE IMMUNOENZYMATIC LABELING OF CELLULAR CONSTITUENTS
    MASON, DY
    SAMMONS, R
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1978, 31 (05) : 454 - 460
  • [10] EXPRESSION OF MESSENGER-RNA AND IMMUNOREACTIVITY FOR THE GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR IN ACTIVATED HUMAN EOSINOPHILS
    MOQBEL, R
    HAMID, Q
    YING, S
    BARKANS, J
    HARTNELL, A
    TSICOPOULOS, A
    WARDLAW, AJ
    KAY, AB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (03) : 749 - 752